Search

Your search keyword '"Catalano, Gloria"' showing total 7 results
Start Over Author "Catalano, Gloria"
7 results on '"Catalano, Gloria"'

1. Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control

Author

Ruggeri, Annalisa, primary, Corrado, Francesco, additional, Voza, Antonio, additional, Wei, Lee-Jen, additional, Catalano, Gloria, additional, Liberatore, Carmine, additional, Nitti, Rosamaria, additional, Fedeli, Carlo, additional, Bruno, Alessandro, additional, Calabretta, Eleonora, additional, Giglio, Fabio, additional, Sciutti, Fabio, additional, Lunghi, Francesca, additional, Landoni, Giovanni, additional, Aghemo, Alessio, additional, Iacobelli, Massimo, additional, Querini, Patrizia Rovere, additional, Richardson, Paul G., additional, Assanelli, Andrea, additional, Peccatori, Jacopo, additional, Ciceri, Fabio, additional, and Carlo-Stella, Carmelo, additional

Published
2024
Full Text
View/download PDF

2. P1572: COVID-19 MORTALITY IN HIGH-RISK PATIENTS AFTER ALLO-HSCT AND CAR-T: IMPROVED OUTCOME THROUGH A PANDEMIC.

Author

Sannipoli, Daniele, primary, Camilla, Gariazzo, additional, Farina, Francesca, additional, Diral, Elisa, additional, Bruno, Alessandro, additional, Clerici, Daniela, additional, Marktel, Sarah, additional, Canziani, Luca, additional, Catalano, Gloria, additional, Fiore, Paolo, additional, Oltolini, Chiara, additional, Querini, Patrizia Rovere, additional, Corti, Consuelo, additional, Ciceri, Fabio, additional, Vitali, Giordano, additional, and Lupo-Stanghellini, Maria Teresa, additional

Published
2023
Full Text
View/download PDF

3. PB2426: SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE

Author

Diral, Elisa, primary, Furnari, Giulia, additional, Farina, Francesca, additional, Clerici, Daniela, additional, Marktel, Sarah, additional, Greco, Raffaella, additional, Catalano, Gloria, additional, Bruno, Alessandro, additional, Campodonico, Edoardo, additional, Xue, Elisabetta, additional, Mastaglio, Sara, additional, Vago, Luca, additional, Stefano Luca Bernardi, Massimo, additional, Carrabba, Matteo Giovanni, additional, Corti, Consuelo, additional, Peccatori, Jacopo, additional, Ciceri, Fabio, additional, and Teresa Lupo Stanghellini, Maria, additional

Published
2023
Full Text
View/download PDF

4. PB2575: HIGH INCIDENCE OF RESPIRATORY TRACT INFECTIONS FOLLOWING COVID-19 WAVES IN PATIENTS WITH PLASMA CELL DYSCRASIAS

Author

Farina, Francesca, primary, Marktel, Sarah, additional, Ferla, Valeria, additional, Clerici, Daniela, additional, Daniele, Sannipoli, additional, Perini, Tommaso, additional, Catalano, Gloria, additional, Oltolini, Chiara, additional, Stanghellini, Maria Teresa Lupo, additional, Corti, Consuelo, additional, Ciceri, Fabio, additional, and Marcatti, Magda, additional

Published
2023
Full Text
View/download PDF

5. Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report.

Author

Diral, Elisa, Catalano, Gloria, Cicinelli, Maria Vittoria, Distefano, Andrea, Mastaglio, Sara, Vago, Luca, Lupo Stanghellini, Maria Teresa, Bernardi, Massimo, Ponzoni, Maurilio, Ciceri, Fabio, and Carrabba, Matteo G.

Subjects
CHRONIC leukemia, STEM cell transplantation, ACUTE myeloid leukemia, BLOOD diseases, THERAPEUTICS, VISION disorders
Abstract

Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a "watch and wait" strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial

Author

Ruggeri, Annalisa, primary, Voza, Antonio, additional, Liberatore, Carmine, additional, Catalano, Gloria, additional, Corrado, Francesco, additional, Di Filippo, Luigi, additional, Nitti, Rosamaria, additional, Fedeli, Carlo, additional, Bruno, Alessandro, additional, Calabretta, Eleonora, additional, Giglio, Fabio, additional, Sciutti, Fabio, additional, Lunghi, Francesca, additional, Landoni, Giovanni, additional, Richardson, Paul G., additional, Iacobelli, Massimo, additional, Aghemo, Alessio, additional, Rovere-Querini, Patrizia, additional, Assanelli, Andrea A., additional, Peccatori, Jacopo, additional, Ciceri, Fabio, additional, and Carlo-Stella, Carmelo, additional

Published
2021
Full Text
View/download PDF

7. SIE/Sies/GITMO Criteria in Elderly Patients with Acute Myeloid Leukemia (AML): Useful Also in the New Drug Era? a Multicentric Real-Life Study By the Hematological Network Rete Ematologica Lombarda (REL)

Author

Borlenghi, Erika, Masina, Lorenzo, Frigeni, Marco, Lotesoriere, Ivana, Molteni, Alfredo, Fumagalli, Monica, Riva, Marta, Zappasodi, Patrizia, Bernardi, Massimo, Fracchiolla, Nicola, Gigli, Federica, Basilico, Claudia, Pagani, Chiara, Lussana, Federico, Perfetti, Paola, Cattaneo, Chiara, Tajana, Monica, Viola, Silvia, Martini, Gianluca, Catalano, Gloria, Sciumè, Mariarita, Condorelli, Annalisa, Cela, Giselda, Rossi, Giuseppe, Tucci, Alessandra, Cairoli, Roberto, and Todisco, Elisabetta

Abstract

Introduction:In elderly acute myeloid leukemia (AML) patients (pts) the debate about the use of intensive chemotherapy (iC) as opposed to non-intensive therapy (niT) or best supportive care (BSC) is a hot topic, particularly after the introduction of venetoclax (VEN) use. Age, comorbidities, functional impairment, therapy benefits and risks, pts preferences, and AML features influence this choice. The SIE/SIES/GITMO (“fitness”) criteria (Ferrara, 2013) are a valuable and comprehensive tool, but a revalidation is needed in the light of the new treatment options.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results